CN Patent

CN102134231A — 二肽基肽酶抑制剂

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2011-07-27 · 15y expired

What this patent protects

本发明提供了用于DPP-IV和其他S9蛋白酶的化合物、药物、药盒和方法，包括式I化合物：其中M是N或CR 4 ；Q 1 和Q 2 各自独立地选自下组：CO、SO、SO 2 和C＝NR 9 ；每一R 1 、R 2 、R 3 、R 4 和R 9 是如本文所定义的。

USPTO Abstract

本发明提供了用于DPP-IV和其他S9蛋白酶的化合物、药物、药盒和方法，包括式I化合物：其中M是N或CR 4 ；Q 1 和Q 2 各自独立地选自下组：CO、SO、SO 2 和C＝NR 9 ；每一R 1 、R 2 、R 3 、R 4 和R 9 是如本文所定义的。

Drugs covered by this patent

Patent Metadata

Patent number: CN102134231A
Jurisdiction: CN
Classification: —
Expires: 2011-07-27
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.